Fda Approval Calendar 2025. A look ahead for 2024. Sign up or log in to access our enhanced fda calendar!
Amgen has gained fda approval of its biosimilar version of johnson & johnson’s stelara, but the copycat is not likely to launch until 2025 because of a prior. The fda’s 2024 pdufa calendar is far from complete, but already it contains several dates worth watching, from the first new drug class for schizophrenia.